ArticleMikrochimica acta2026
Dual-mode photothermal and colorimetric immunosensor based on polydopamine@Prussian blue nanocomposite for sensitive detection of benzocaine.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A dual-mode immunosensor based on polydopamine@Prussian blue nanoparticles (PDA@PB NPs) was developed for rapid and sensitive detection of benzocaine (BZC) in aquatic food. PDA@PB NPs possess excellent peroxidase-like activity, photothermal conversion efficiency, and antibody-binding capacity, enabling simple, crosslinker-free antibody immobilization. Upon target recognition, the sensor produces a distinct blue color via TMB–H2O2 oxidation and a robust near-infrared photothermal signal, allowing dual-mode quantitative determination. Under optimized conditions, the sensor showed a linear range of 0.01–1000 ng/mL, with detection limits of 0.33 ng/mL (colorimetric) and 0.82 ng/mL (photothermal). The integration of colorimetric and photothermal outputs improves detection accuracy, reduces matrix interference, and eliminates the need for complex instrumentation. Validation with spiked real samples confirmed its reliability and applicability. This portable, cost-effective immunosensor offers a promising tool for on-site monitoring of BZC residues in aquatic products, contributing to enhanced food safety surveillance.
Indexed as
Identifiers
41653196What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.